Stock Events

Stock Events

Nightingale Health Oyj 

$1.5200
12
+$0.00+0%Thursday 20:00

Statistics

Day High
1.52
Day Low
1.52
52W High
2.55
52W Low
0.9156
Volume
100
Avg. Volume
10,000
Mkt Cap
61.61M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Sep 16Expected
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.2
-0.18
-0.16
-0.14
Expected EPS
-0.1655987
Actual EPS
-0.18179996316

Financials

-336.1%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
6.36MRevenue
-21.36MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NHLTY. It's not an investment recommendation.
Nordea Bank Abp
4
NDA-FI.HE
Fortum Oyj
4
FORTUM.HE
Neste OYJ
4
NESTE.HE
Metso
3
METSO.HE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap35.63B
Illumina provides genomic sequencing and array-based technologies which are fundamental in personalized health solutions, similar to Nightingale's health analytics.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific offers biotechnology product development including diagnostics and healthcare solutions that overlap with Nightingale's offerings.
Guardant Health
GH
Mkt Cap23.99B
Guardant Health specializes in blood-based cancer diagnostics, competing in the liquid biopsy space where Nightingale also operates.
Qiagen NV
QGEN
Mkt Cap10.37B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, and academic research, competing in the diagnostics space.
Bio-Rad Laboratories
BIO
Mkt Cap9.95B
Bio-Rad Laboratories manufactures and supplies products and systems used for gene expression which are used in similar applications as Nightingale's technologies.
Fulgent Genetics
FLGT
Mkt Cap567.37M
Fulgent Genetics offers comprehensive genetic testing, directly competing with Nightingale's approach to health diagnostics through genetic insights.
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences provides advanced DNA sequencing systems that compete with Nightingale's genomic analysis technologies.
Quest Diagnostics
DGX
Mkt Cap27.79B
Quest Diagnostics provides diagnostic testing, information, and services that overlap with Nightingale's health diagnostic solutions.

About

NIGHTINGALE HEALTH OYJ
Show More
CEO
Mr. Teemu Suna
Country
Finland
ISIN
US6541031000

Listings

OTC Link
US
NHLTY
MU
DE
7XE.MU
F
DE
7XE.F
HE
FI
HEALTH.HE

0 Comments

Share your thoughts

FAQs

What is Nightingale Health Oyj stock price today?▼
The current price of NHLTY is $1.52 USD — it has increased by +0% in the past 24 hours. Watch Nightingale Health Oyj stock price performance more closely on the chart.
What is Nightingale Health Oyj stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Nightingale Health Oyj stocks are traded under the ticker NHLTY.
What is Nightingale Health Oyj market cap?▼
Today Nightingale Health Oyj has the market capitalization of 61.61M
When is the next Nightingale Health Oyj earnings date?▼
Nightingale Health Oyj is going to release the next earnings report on March 9, 2027.
What were Nightingale Health Oyj earnings last quarter?▼
NHLTY earnings for the last quarter are -0.18 USD per share, whereas the estimation was -0.17 USD resulting in a -9.78% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nightingale Health Oyj revenue for the last year?▼
Nightingale Health Oyj revenue for the last year amounts to 6.36M USD.
What is Nightingale Health Oyj net income for the last year?▼
NHLTY net income for the last year is -21.36M USD.
In which sector is Nightingale Health Oyj located?▼
Nightingale Health Oyj operates in the Other sector.
When did Nightingale Health Oyj complete a stock split?▼
Nightingale Health Oyj has not had any recent stock splits.
Where is Nightingale Health Oyj headquartered?▼
Nightingale Health Oyj is headquartered in Helsinki, Finland.